Corteva Just Split in Two. Here’s What Shareholders Own Now

Corteva shareholders woke up to what looked like an 83% crash, but the real story is what they now own across two tickers and a lawsuit that could unwind the entire split.

Published October 2, 2026, 2:10pm ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A wide-angle landscape photo under a partially cloudy blue sky. On the left, a vibrant green field of young crops extends to the horizon. On the right, a golden-yellow field of harvested stalks stretches alongside. A clear, diagonal dirt path separates the two fields, leading to a bare, leafless tree standing prominently in the middle distance at the horizon line. In the far distance, a dense line of trees forms a dark green and light brown border.
The image of two distinct fields, one green and one harvested, with a clear dividing line, mirrors the recent two-way split of agricultural giant Corteva. Shareholders now navigate the separate paths of the newly formed entities. © Milosz_G / Getty Images

On October 1, 2026, anyone who checked Corteva (NYSE:CTVA | CTVA Price Prediction) in a brokerage app saw what looked like a collapse. The stock fell 83.82% in a single session and closed at $12.56, down from a prior close of $77.65.

CTVA price target

The value of a Corteva position now sits in two tickers. Corteva finished spinning off its seed business into a separate company, Vylor (NYSE:VYLR), and the drop on the screen simply reflects that business leaving the parent.

Corteva said holders of record on September 24 received one Vylor share for every Corteva share they owned. That leaves holders with two very different companies to evaluate. One of these companies sells seed, and the other sells farm chemicals, and a lawsuit naming both was filed the same day the split closed.

What Happened to Your Account

In a spin-off, one company becomes two. Existing holders receive shares of the new company while the parent’s share price falls by the value of the business that left.

Vylor traded at $67.46 on its first day. At that price, one Corteva share plus one Vylor share was worth $80.02, above the $77.65 prior close. Vylor’s first-day close was approximately $68.26.

Vylor said the distribution is tax-free for US holders. Cash paid for fractional shares is taxable.

Two Very Different Businesses

Vylor holds the seed and genetics business, including Pioneer and Brevant brands, targeting 2029 net sales of $11.2 billion to $11.9 billion. Seed is an intellectual-property business built on trait licensing and long development cycles.

Corteva kept crop protection: herbicides, insecticides, and fungicides. In the second quarter of 2026, seed sales were $4.532 billion and flat, while crop protection brought in $1.847 billion and fell 4%.

CTVA earnings explorer

Why Management Split Them

A combined company can hide its stronger business inside its weaker one, while a pure seed company will be valued on its own multiple, and a crop-protection company judged on its own results. Luke Kissam, Corteva’s chief executive, said, “This is a new day for Corteva.” The company guided to about $350 million in one-time separation costs.

Fifteen states and Guam sued both companies in Indiana. The suit says the spin-off is a fraudulent transfer designed to keep assets from creditors with PFAS claims. Corteva called the claims speculative and unproven.

The company also said, “Corteva itself never made or sold PFAS products.” If the suit wins, a court could pull the separated company back into the liability, wiping out the clean break both sides are counting on.

What Could Change the Outlook for Corteva and Vylor

Vylor likely holds the stronger position. The remaining Corteva is the smaller business, with falling sales and generic competition that seed traits protect it from.

Corteva has also not announced a dividend policy, so any yield you see quoted is based on the old combined company, and Vylor has no trading history yet, so its first-day price is only a starting point for evaluating the company.

If Corteva’s first standalone third-quarter 2026 report shows crop protection sales growing again and comes with a clear dividend, I am wrong about CTVA.

Contact [email protected] for any questions or corrections.

Omor Ibne Ehsan

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth, cyclical, and dividend equities that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as penny stocks.

All articles →